Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/1/05 → 6/30/07 |
A Phase II study of BMA-354825 in Subjects with Accelerated Phase Chronic Myeloid Leukemia Who have Disease that is Resistant to Imatinib Mesylate (Gleevec) or Who are Intolerant of Imatinib Mesylate
- Brown, Randy (PI)